Vanguard Global Advisers’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
Other funds holding IMVT
Vanguard Global Advisers's IMVT Position: Q3 2026 in Review
Vanguard Global Advisers increased its Immunovant (IMVT) stake by 3.4% in Q3 2026, buying an estimated $49.1K and bringing the position to 38,447 shares worth $1.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1543.
Vanguard Global Advisers first reported a position in IMVT in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.43M in Q2 2026. 232 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.
- Vanguard Global Advisers held 38,447 shares of Immunovant worth $1.3M as of Q3 2026.
- Vanguard Global Advisers bought 1,247 Immunovant shares in Q3 2026, an estimated $49.1K.
- Immunovant made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1543 holding.
- Vanguard Global Advisers first reported a position in Immunovant in Q1 2026 and has held it in 3 quarters since.
- Vanguard Global Advisers's Immunovant position peaked at $1.43M in Q2 2026.
- 232 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.